Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Metastatic Hormone Sensitive Prostate Cancer
Seattle, Washington
Metastatic Hormone Sensitive Prostate Cancer Clinical Trials in Seattle, Washington
1 recruiting
Seattle, Washington
Showing
1–1
of
1
trials
Recruiting
Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone Sensitive Prostate Cancer
Novartis Pharmaceuticals
150 enrolled
67 locations
NCT06991556
Feedback